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Abstract
The molecular landscape of non-tobacco-induced primary lung tumors dis-
plays specific oncogenetic features. The etiology of these tumors has been largely 
associated with exposure to well-established environmental lung carcinogens such 
as radon, arsenic, and asbestos. Environmental carcinogens can induce specific 
genetic and epigenetic alterations in lung tissue, leading to aberrant function of 
lung cancer oncogenes and tumor suppressor genes. These molecular events result 
in the disruption of key cellular mechanisms, such as protection against oxidative 
stress and DNA damage-repair, which promotes tumor development and progres-
sion. This chapter provides a comprehensive discussion of the specific carcinogenic 
mechanisms associated with exposure to radon, arsenic, and asbestos. It also 
summarizes the main protein-coding and non-coding genes affected by exposure 
to these environmental agents, and the underlying molecular mechanisms promot-
ing their deregulation in lung cancer. Finally, the chapter examines the anticipated 
challenges in personalized intervention strategies in non-tobacco-induced lung 
cancer.
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1. Introduction
Lung cancer remains the deadliest form of cancer across the globe [1]. While 
smoking rates have decreased in many areas, it remains to be seen if the incidence 
and mortality of primary lung cancer will experience a similar shift, particularly 
in light of the observation that close to 25% of cases arise in individuals who have 
never smoked [2]. As one of the most environmentally-influenced malignancies, 
lung tumorigenesis can result from exposure to both physical and chemical carcino-
gens. Exposure to the mix of compounds present in particulate matter is another 
well-known factor affecting the development of lung cancer [3]. However, a num-
ber of single-agent compounds in the environment have been identified as key lung 
carcinogens, particularly arsenic, asbestos and radioactive radon (222Rn) gas [4]. 
These compounds are distributed at varying, potentially-dangerous concentrations 
in the environment, affecting hundreds of millions of people worldwide.
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Exposure to each of arsenic, asbestos, and radon has been shown to induce 
widespread genetic and epigenetic alterations, which may account for their strong 
carcinogenicity, independent of smoking status [4]. Interestingly, the molecular 
aberrations associated with these compounds and the onset of lung cancer in 
never-smokers follows a mechanism distinct from that of tobacco smoke [5]. While 
strict guidelines regarding exposure to these compounds have been implemented 
in some regions, mounting evidence suggests that carcinogenic effects may result 
from chronic exposure to environmental levels that are well below those currently 
deemed “safe” [6, 7]. Additionally, individual differences may contribute to varying 
degrees of susceptibility to the carcinogenic effects of these compounds. For 
instance, women have been shown to have a higher incidence of lung cancer arising 
in never-smokers. This inequality can potentially be attributed to a historical bias 
towards women being more present in the home, resulting in increased exposure 
to high radon concentrations and polyaromatic hydrocarbons from various home 
combustion sources [8]. As these genetic and epigenetic aberrations might be 
indicative of specific molecular damage induced by these carcinogens, they may be 
able to be used to develop personalized approaches for risk assessment, monitoring 
and subsequent disease treatment. Thus, it is critical to uncover the extent of these 
events associated with exposure to environmental carcinogens.
Arsenic is a class I International Agency for Research on Cancer (IARC) carcino-
gen that threatens global health through its persistent accumulation in drinking 
water sources, leading to the onset of skin and lung cancers, among other diseases 
[9]. Asbestos fibers are naturally occurring silicate mineral fibers that have long 
been used in industry as building insulation, and are closely linked with not only 
the well-known outcome of mesothelioma, but also to 5–7% of all lung cancer 
cases [10]. Radon gas accounts for between 3 and 14% of all lung tumors in a given 
country and is the second most-common cause of lung cancer, behind smoking 
[11]. While the radioactive gas normally diffuses easily in open air, it can build 
up in indoor environments and is readily dissolved into water, which can lead to 
malignancies through radioactive decay and alpha particle emission [11]. Moreover, 
drinking water may be a particularly prevalent source of exposure to environmental 
carcinogens, as it is a primary route of exposure for both arsenic and radon, empha-
sizing the need for a focus on water contamination measurement and remediation. 
As arsenic, asbestos, and radon exert their carcinogenic effects through different 
exposure routes, they display similar, yet distinct mechanisms of genetic and 
epigenetic aberration, which may be useful in the identification and treatment of 
tumors caused by these agents.
In this chapter we highlight the molecular alterations induced by exposure 
to arsenic, asbestos, and radon in key lung cancer pathways, and finish with a 
discussion of the potential translational applications of environmentally-induced 
molecular damage.
2. Arsenic
2.1 Physiological and molecular impact of exposure
Arsenic exposure largely occurs through contaminated drinking-water sources, 
but this problem extends well beyond known arsenic-endemic areas. In fact, it is 
estimated that 200 million individuals are exposed worldwide to levels deemed 
non-toxic by the WHO, but shown to induce molecular damage [12].
The toxic effects of arsenic are prevalent from ingestion to excretion and are 
largely attributed to its various metabolites (Figure 1). Once ingested, arsenate 
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(AsV)—the most common form of the compound in the environment—is taken into 
cells through membrane transporters, where it is quickly reduced to arsenite (AsIII) 
by oxidoreductases including purine nucleotide phosphorylase (PNP) and glutathi-
one-s-transferase omega (GSTO). AsIII is the most toxic form of arsenic, largely due 
to its subsequent methylation by methyltransferase enzymes such as arsenic (+3) 
methyltransferase (As3MT), a process exploited for promoting the excretion of arse-
nic [13]. However, methyl groups are provided by S-adenosylmethionine (SAM), a 
key cellular methyl group donor. Methylation of arsenic inside the cell can thus lead 
to the depletion of the cellular methyl pool through a high demand on SAM, which 
then promotes global DNA hypomethylation and aberrant histone modification 
[14–17]. Disruptions in the cellular methyl pool can lead to major disruptions in 
gene expression, which is known to contribute to malignant transformation [16].
The genomic instability and global changes in gene expression resulting from 
the exposure and biotransformation of arsenic is exacerbated by the widespread 
induction of DNA damage from toxic arsenic byproducts. In fact, arsenic has been 
demonstrated to cause distinct alterations in chromatin, gene expression (both 
coding and non-coding), as well as splicing, and transcription initiation [18]. 
In particular, one of the methylated species of arsenic, monomethylarsonic acid 
(MMAIII), can interrupt the electron transport chain in mitochondria, liberating 
electrons and inducing the formation of reactive oxygen species (ROS) [15, 19, 20]. 
ROS generated from arsenic exposure result in widespread DNA damage, including 
single- and double-stranded DNA breaks, DNA base oxidation leading to muta-
tions (largely G>C → T>A transversions), adducts, deletions and even damage 
to mitochondrial DNA (mtDNA) [20–22]. Unsurprisingly, as oxidative stress is a 
known driver of tumorigenesis in multiple tissues, the DNA damage induced from 
arsenic exposure is thought to be a main mechanism of its carcinogenicity [23–25]. 
The disruption of the electron transport chain produces ROS such as hydroxyl 
Figure 1. 
Molecular mechanisms of arsenic-induced carcinogenesis.
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radicals (OH∙), superoxide anion radicals (O2∙−), and hydrogen peroxide (H2O2), 
which can further damage cells through lipid oxidation, protein oxidation, and 
reduction of the mitochondrial membrane potential [26]. The subsequent libera-
tion of cytochrome c can activate apoptotic pathways through caspases, leading to 
an abnormal rate of cell death. However in addition to faulty apoptotic signaling, 
exposure to arsenic can also lead to further aberrations in DNA-repair pathways. 
Here, arsenic affects the expression of genes involved in both nucleotide- (NER) 
and base-excision repair (BER) mechanisms, allowing the cell to continue through 
the cell cycle despite extensive damage and genomic instability [27–30]. Thus, 
arsenic exposure can induce an array of molecular damage across the genome and 
epigenome, culminating in malignant transformation.
2.2 Carcinogenic mechanisms
While it is exposure to the methylated metabolic byproducts that yields the 
largest toxic effects resulting from exposure to environmental arsenic, it is notewor-
thy that even at very low doses, arsenic may be able to act as a co-mutagen to other 
known carcinogens, such as ultraviolet light, X-rays, methyl methane sulfonate, 
and tobacco smoke [15]. ROS are perhaps more immediately damaging to cells, as 
they can lead to alterations in a variety of lung cancer-specific pathways. As stated 
previously, arsenic exposure can interfere with DNA damage repair pathways, 
which exacerbates the effects of ROS generation. In the NER pathway, arsenic can 
alter the expression of key damage-repair genes, such as XPC, in a process that may 
be mediated by the proteasome [31].
Collectively, aberrations in cellular DNA-damage repair pathways may not only 
highlight mechanisms of arsenic toxicity, but also its co-mutagenic effects. One of 
the most common pathways affected in lung cancer is the constitutive activation of 
the epidermal growth factor receptor (EGFR), especially in women and individuals 
who have never smoked [32]. Both amplification and mutation can lead to EGFR 
activation, which subsequently stimulates cell proliferation. AsIII can activate proto-
oncogene c-Src (c-Src) through vicinal sulfhydryl groups, which then promotes 
phosphorylation events in intracellular EGFR tyrosine residues (Tyr845) [32]. As 
tyrosine phosphorylation is a key event in EGFR activation, AsIII thus promotes 
EGFR constitutive signaling. Alternatively, arsenic exposure may also indirectly 
affect downstream members of the EGFR pathway, through arsenic-induced 
oxidative stress and ROS, a common mechanism of environmentally-induced 
lung carcinogenesis. In a mechanism similar to that of EGFR activation, arsenic 
has been shown to induce the phosphorylation of several potential substrates of 
protein kinase B (Akt), a regulator of epithelial-to-mesenchymal transition (EMT) 
and metastasis, inducing cell migration [33]. Specifically, arsenic may affect 
c-Jun N-terminal kinase (JNK) activation and subsequent activation of signal 
transducer and activator of transcription 3 (STAT3), resulting in Akt growth and 
migration signaling [34]. Similarly, arsenic may increase the enzymatic activity of 
phosphoinositide 3-kinase (PI3K) and Akt phosphorylation, a key pathway in lung 
cancer tumorigenesis and progression [35]. The mechanism of PI3K/AKT activation 
has proven elusive, yet evidence suggests that ROS may play a mediating role, as 
well as alterations in histone modifications and activation of other related path-
ways, such as EGFR, mammalian target of rapamycin (mTOR), or polo-like kinase 
1 (PLK1) signaling [35, 36]. Phenotypically, activation of the PI3K/Akt signaling 
axis by arsenic can result in a variety of changes, including cellular growth and 
angiogenesis [37]. There are many other lung cancer-specific pathways that may 
be altered upon exposure to arsenic and its toxic byproducts, including the nuclear 
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factor (erythroid-derived 2)-like 2/kelch-like ECH-associated protein 1 (NRF2/
KEAP1) pathway, the nuclear factor kappa-light-chain-enhancer of activated B cells 
pathway (NF-κB), and various epigenetic pathways [35, 38]. Further experimental 
work is required to fully characterize and distinguish the molecular mechanisms of 
the pathways affected by chronic exposure to arsenic.
2.3 Prominent cancer genes affected by arsenic
As evidenced by its genome-wide effects on cellular physiology and molecular 
pathways, gene expression alterations cause by arsenic exposure can potentiate 
negative health outcomes. In fact, there are a growing number of genes that have 
been observed to have abnormal expression resulting from arsenic exposure, in 
cell lines, mouse, and human samples. Many of these genes have accepted roles in 
cancer, both as tumor-suppressors and oncogenes. Most notably, the tumor suppres-
sor gene TP53 has been shown to be epigenetically inactivated in arsenic-exposed 
cell lines [39]. Similarly, other cell line studies have suggested that low concentra-
tions of arsenic may upregulate the known lung oncogene Myc (also related to the 
cell cycle) through aberrant expression of miRNAs targeting upstream regulators of 
its transcription [40].
As previously discussed, the frequent disruption of DNA damage repair and 
stress response pathways is a common feature of arsenic-induced lung tumors. 
Notably, arsenic has been associated with stimulation of the DNA damage response 
through the upregulation of critical genes, such as the gene encoding DNA excision 
repair protein ERCC1 (ERCC1) [41], confirming that DNA damage is prevalent 
in arsenic-exposed individuals. Alternatively, arsenic may induce repression and 
decreased activity of main DNA repair enzymes, including poly [ADP-ribose] 
polymerase 1 (PARP1) inhibition (through ROS) [42], proteasomal degradation of 
xeroderma pigmentosum, complementation group C (XPC) [31], and widespread 
hypermethylation of NER genes [43]. Additional lung cancer-related genes affected 
by arsenic include: EGFR [44], cyclin-dependent kinase inhibitor 1A (CDKN1A) [45], 
and B-cell lymphoma 2 (BCL2) [46]. Despite the mounting evidence of the toxic 
effects of arsenic, the concentration and identity of key damage-related arsenic 
compounds varies widely between studies. While different arsenic-based com-
pounds affect similar pathways, specific physiological responses may vary greatly 
depending on compound type and dose response, necessitating closer examination 
of these factors in future studies.
However, it is important to note that variations in these genes may exist within 
individuals prior to arsenic exposure, and that certain genetic polymorphisms may 
make some individuals more susceptible to the genotoxic effects of arsenic. For 
instance, a single nucleotide polymorphism (rs238406; C > A) in ERCC2 (part of 
the DNA-damage response) leads to the inclusion of an alanine residue in the place 
of a cysteine in the complete protein, increasing an individual’s odds ratio for skin 
cancer to 2.04 [47]. Additionally, polymorphisms in many of the genes involved in 
the metabolism and biotransformation of arsenic may result in the production of 
different metabolic byproducts, conferring differential susceptibility and cancer 
risk [48]. This is exemplified by the rs1191439 polymorphism of As3MT, which is 
correlated with elevated MMA levels in urine [49]. Thus, the landscape of arsenic-
induced carcinogenesis is quite complex, with multiple types and outcomes of the 
molecular aberrations that can result from chronic exposure. A more comprehen-
sive understanding of the mechanisms at play may result in the identification of 
the underlying causes of lung cancer in never-smokers, and may help to direct the 




3.1 Physiological and molecular impact of exposure
Asbestos is a term used to define a group of mineral fibers incorporated in a 
wide variety of products, including talcum powder, brake pads, and construction 
materials. While more than 50 countries have banned the use of asbestos-containing 
materials, more than 2 million metric tonnes are still produced every year, which 
still poses a great public health risk for asbestos-related diseases [50, 51]. There are 
two main classes of asbestos: chrysotile (spiral-shaped, the most common form) and 
amphibole (needle-shaped). Other elements such as iron (which can constitute up to 
30% of the weight of asbestos fibers) embedded in the surface of fibers can potenti-
ate asbestos-related pathogenic effects [52, 53]. Importantly, all identified forms of 
asbestos have been classified as carcinogens to humans (Group 1) by the IARC [54].
Exposure to asbestos fibers has been strongly linked to the development of 
malignant mesothelioma, but it is also a known contributor to the development 
of lung cancer [55–57]. Between 5 and 7% of all lung cancer cases worldwide have 
records of high levels of asbestos, mostly derived from occupational exposure (e.g., 
mining) [10]. Exposure is usually determined by the presence of pleural plaques 
(areas of fibrosis associated with past exposure to asbestos), or by detection of 
asbestos fibers in bronchoalveolar lavage (BAL) and lung tissue [58]. The primary 
source of asbestos exposure comes from inhaled fibers [54]. However, the mecha-
nism of disruption that occurs as a result of asbestos exposure is determined by the 
efficiency of fiber clearance from airway cells. Longer fibers are cleared at a slower 
rate than short fibers, and are associated with higher carcinogenic potential [59]. 
Similarly, thin fibers (width <0.25 μm) are more carcinogenic than thicker ones 
[60], likely because they can penetrate deeper in airways. Accumulation of asbestos 
fibers in the lung leads to fibrosis, inflammation, and carcinogenesis, although spe-
cific effects depend on the cumulative dose and the type of fiber inhaled [61, 62].
Asbestos-related carcinogenesis is thought to primarily result from the ability of 
the fibers to induce oxidative stress (Figure 2), although the specific mechanisms 
are not yet fully understood [63]. Asbestos induces the recruitment of alveolar 
macrophages, followed by an inflammatory reaction [64–66]. Failed phagocytosis 
of these fibers by macrophages results in the generation of ROS, together with the 
release of cytokines, chemokines, proteases, and growth factors further amplify-
ing deleterious effects of asbestos [10, 56, 67]. Additionally, the iron contained in 
asbestos fibers deposits in the lungs and cycles between the reduced and oxidized 
forms, potentially inducing further oxidative DNA damage in nearby cells via the 
Fenton reaction which converts H2O2 into more reactive ROS [10, 56, 68, 69].
In lungs, oxidative stress following asbestos exposure can activate several 
signaling pathways including mitogen-activated protein kinases (MAPK), NF-κB, 
and activator protein 1 (AP1). All of these pathways have been linked to increases in 
early response genes (e.g., JUN and FOS) that govern cell proliferation, apoptosis, 
and inflammatory signaling [55, 56].
3.2 Carcinogenic mechanisms
The most frequent asbestos-induced alterations in cancer-related genes have 
been reported in tumor suppressor genes (TSGs). Activation of p53 and p21 are 
frequently described, both in animal models and lung cancer patients with asbes-
tosis (reviewed in [63]). This likely represents the initial DNA-damage response 
following exposure to asbestos-induced oxidative stress. In lung cancer patients, 
the frequency of TP53 gene mutations is similar between asbestos-exposed and 
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unexposed NSCLC cases; however, a higher frequency of G:C to T:A transversions 
in the sequence of TP53 is observed in asbestos-exposed cases [70, 71]. Contrarily, 
other tumor suppressor genes such as CDKN2A are inactivated in asbestos-exposed 
lung cancer cases, mostly via segmental copy-number losses [72]. In murine models, 
chrysotile fibers are able to induce the activity of the c-Jun and c-Fos oncogenes and 
inactivate p53 and p16 tumor suppressors, both at the mRNA and protein levels [73].
Additionally, other well-known lung cancer genes and pathways have been 
shown to display aberrant functions in response to asbestos exposure. Different 
mechanisms of asbestos-mediated activation of the EGFR pathway have been 
described. Asbestos-induced chronic inflammation has been associated with activa-
tion of the EGFR-related and extracellular signal-regulated kinase (ERK) signaling 
pathway that promote lung epithelial cell and fibroblast proliferation [55, 56, 74]. 
Also, asbestos fibers can induce over-expression of EGFR mRNA and induce protein 
dimerization, phosphorylation, and subsequent pathway activation by directly 
interacting with the surface portion of the receptor [63, 75, 76]. On the other hand, 
DNA mutations affecting EGFR do not seem to be main mechanisms of asbestos-
induced EGFR activation. Asbestos-exposed patients displayed a significantly lower 
rate of EGFR mutations compared to non-exposed patients [77]. Moreover, it is 
unclear if there is a causal relationship between the mutations found in EGFR and 
exposure to asbestos fibers [78, 79].
Other genes, such as MAP4K3, CEBPZ, QPCT, FANCG, IGFBPL1, CCL19, 
MELK, FANCM, and CDKL1 have shown aberrant gene expression in human  
epithelial bronchial cell lines (Beas-2B), following asbestos exposure [80]. 
Asbestos inhalation also causes up-regulation of mRNA levels of matrix metal-
loproteinase family members in rat lungs, suggesting induction of extracellular 
matrix remodeling [81].
Figure 2. 
Molecular mechanisms of asbestos-induced carcinogenesis.
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At the epigenetic level, alterations affecting tumor suppressor genes have been 
observed in lung cancer cases associated with asbestos exposure, including those 
in the promoter regions of RASSF1A and CDKN2A (p16) [82]. Additionally, a 
genome-wide DNA methylation study identified differentially methylated CpGs in 
regions nearby the transcription start site of genes such as NPTN, NRG2, GLT25D2 
and TRPC3 to be significantly associated with asbestos exposure [83].
The effect of asbestos on micro RNA (miRNA) expression has been also investi-
gated. miRNAs are short (~22 nucleotide) RNA transcripts that negatively regulate 
gene expression through direct interaction with mRNAs. Interestingly, the over-
expression of miR-148b has been described in multiple independent studies. This 
miRNA was part of an asbestos-related signature in lung tumors, also composed 
of seven other overexpressed (miR-374a, miR-24-1*, let-7d, Let-7e, miR-199b-5p, 
miR-331-3p, and miR-96) and five miRNAs with decreased expression in tumors 
(miR-939, miR-671-5p, miR-605, miR-1224-5p, and miR-20) [84]. Additionally, 
miR-148b was found to be overexpressed in asbestos-related lung cancer compared 
to tumors in non-exposed individuals, and three of its targets (GADD45A, LTBP1 
and FOSB) were down-regulated in asbestos-exposed patients [84].
Despite the known genetic and epigenetic abnormalities resulting from asbestos 
exposure, a relatively small proportion of exposed individuals develop thoracic 
malignancies (mesothelioma or lung cancer). It has been hypothesized that specific 
genetic variants may confer increased risk of developing asbestos-related diseases 
[85]. Thus, recent studies have investigated the association between genomic 
variants and risk of lung cancer following asbestos exposure. In a genome-wide 
association study (GWAS) performed in the Texas lung cancer GWAS dataset, the 
authors did not find statistical evidence for gene-asbestos interaction in the etiol-
ogy of lung cancer [86]. However, the Fas signaling pathway (regulation of tissue 
homeostasis in the immune system by inducing apoptosis) was identified as the 
most significant pathway associated with asbestos exposure in the etiology of lung 
cancer. Another study identified three single nucleotide polymorphisms (SNPs) in 
the MIRLET7BHG (MIRLET7B host gene located at 22q13.31) significantly associ-
ated with increased lung cancer risk among individuals exposed to asbestos [36].
The identification of risk variants linked with asbestos-related lung cancer is a 
challenging task. Sample sizes for asbestos-related lung cancer cohorts are particu-
larly limited by the number of cases that can be unequivocally attributed to asbestos 
exposure despite other well-known factors (e.g., smoking). Thus, focusing on the 
genes and chromosomal regions found by these preliminary studies might be useful 
for more targeted strategies aiming to validate these results.
3.3 Carcinogenic potential of other fibers
While the oncogenic effects of asbestos have been extensively established, recent 
evidence indicates that non-asbestos fibers, both natural and synthetic in nature 
can also cause thoracic cancers. Non-asbestos mineral (natural) fibers include 
erionite and fluoro-edenite, among others. Erionite is a naturally occurring fibrous 
mineral that shares some physical properties with asbestos, although it is less 
widespread. In fact, it has been shown that erionite is a more potent carcinogen in 
causing malignant mesothelioma [87, 88]. Erionite activates the NLR family pyrin 
domain containing 3 (NLRP3, NALP3) inflammasome, inducing the transcription 
and production of cytokines critical to cancer initiation [89]. On the other hand, 
Fluoro-edenite (originating from volcanic activity) can induce ROS that result in 
DNA damage and increase in lactic dehydrogenase release (a damage and toxicity 
marker) in human lung adenocarcinoma (A549) and monocyte-macrophage (J774) 
cell lines [90].
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Synthetic graphene-based fibers are widely used in several industries. They 
have also been explored as a drug delivery system for cancer treatments. Physical 
similarities to asbestos, particularly its high length-to-width ratio, have raised some 
concerns about the potential carcinogenicity effects of these fibers [91]. Exposure 
to carbon nanotubules has been shown to induce oncogenic pathways, such as 
TGF-β and Akt/GSK-3β, resulting in activation of the SNAIL-1 signaling pathway 
and epithelial-mesenchymal transition [92]. Additionally, carbon nanotubules can 
generate ROS, activating MAPKs, AP-1, NF-κB, and Akt in normal and malignant 
human mesothelial cells [93]. Other genetic alterations, including micronuclei 
formation, disruption of mitotic spindles, and polyploidy have also been observed 
in response to carbon nanotubule exposure [94–96]. Moreover, it has been shown 
that exposure to carbon nanotubules can induce specific methylation changes at 
the promoter regions several genes, including DNMT1, ATM, SKI, and HDAC4, 
while they seem to have only a marginal effect on miRNA expression [97]. Thus, the 
oncogenetic factors of natural and synthetic fibers, while similar in morphology, 
are distinct entities that may collectively culminate in tumor development.
4. Radon
4.1 Physiological and molecular impact of exposure
Radon is the second most common cause of lung cancer in many countries; 
however, the intricacies of its mechanism of action remain underappreciated. The 
genotoxicity of radon is largely the result of alpha particle emission during its spon-
taneous decay into short-lived radioactive progeny (218Po and 214Po) and comparably 
long-lived radioactive 210Pb, which also induces cellular damage through alpha 
decay (Figure 3) [98].
Alpha decay is the emission of a 4 atomic mass unit helium ion (two protons and 
two neutrons), which can liberate electrons from water molecules and result in the 
generation of several types of ROS [15]. Much like the mechanisms of arsenic and 
asbestos toxicity, ROS generated as a consequence of radon exposure can lead to 
widespread molecular aberrations, especially base oxidation (leading to mismatches 
and mutagenesis), DNA strand breaks, chromosomal aberrations, and deletions. 
For example, chromatid deletions in blood lymphocytes may be a result of radon 
exposure, which may in part explain the associations between radon exposure and 
blood malignancies [8]. These events may occur at levels well below those currently 
deemed safe in many countries, exemplified by the observation of chromosomal 
abnormalities in lymphocytes at very low doses of polonium-214, a radioactive 
progeny of radon [99].
Beyond the molecular events resulting from ROS generation, alpha radiation 
from radon exposure can induce bystander responses in cells that have not been 
directly affected by alpha particles [100]. The bystander effect of radiation expo-
sure can occur through the release of signals from nearby irradiated cells, generat-
ing a physiological response in non-irradiated cells, even at relatively low doses of 
radiation [101]. The effect requires direct contact between adjacent cells, such as 
through gap junctions, as well as compounds in the surrounding medium, includ-
ing cytokines [102]. One of these compounds, nitric oxide (NO), has been shown 
to be an important factor for the cell-killing effects of the bystander response, 
largely through the direct interaction with and damage of DNA [103]. Moreover, 
NO byproducts such as dinitrogen trioxide (N2O3) can promote nitrosation of other 
amines, such as those of DNA bases, leading to cross-linking and DNA alkylation 
[102]. Another compound that may be relevant to the bystander effect of cellular 
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radiation exposure is cyclooxygenase 2 (COX-2), which is related to the NF-κB 
pathway, an effect that is attenuated upon COX-2 inhibition [103, 104]. Finally, this 
response may be dependent on TP53 status, which will be discussed in Section 4.3.
4.2 Carcinogenic mechanisms
Despite differences in the details of exposure, the molecular mechanisms con-
tributing to carcinogenesis in individuals exposed to arsenic, asbestos, and radon 
converge in that they all produce ROS. Radon has a half-life of 3.8 days, and as previ-
ously mentioned, commonly generates alpha particles and polonium decay products, 
which themselves emit further alpha radiation [105]. Alpha particles have a high 
linear energy transfer (LET) despite having relatively low penetration capability, 
meaning that they interact readily with DNA, especially in regions close to their site 
of exposure, such as the bronchial epithelium [105]. Thus, it is not surprising that 
lung malignancies are the most common type of radon-induced cancer. High LET 
radiation is distinct from low LET radiation (such as x-rays or gamma rays) in that it 
produces a substantially greater proportion of clustered damage, meaning the  
occurrence of ≥2 lesions of ≥1 different types within 1–2 helical turns of 
DNA. Clustered DNA damage is typically repaired with slower kinetics and has a 
greater likelihood of producing sequence alterations, as repair pathways converge 
and conflict with one another [106–108].
Figure 3. 
Molecular mechanisms of radon-induced carcinogenesis.
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The largest radon-induced mechanisms of carcinogenesis include DNA damage, 
ROS, and alpha particle generation; likewise, pathways associated with these func-
tions are also known to be associated with lung cancer. In fact, patients positive for 
rearrangements in the gene encoding anaplastic lymphoma kinase (ALK)—an event 
frequently found to drive lung tumorigenesis—were found to have two-fold increases 
in residential radon levels than those without these rearrangements [109, 110]. While 
a synergistic effect between radon and smoking has been suggested [11], the G:C 
to T:A transversions associated with tobacco-related molecular damage are not as 
commonly observed in individuals exposed to radon, suggesting a unique molecular 
signature in radon-associated lung tumors [15]. Again, it is important to note that 
a number of the pathways affected by radon exposure, including gene expression 
alterations and apoptotic disturbances, may actually be from cells neighboring those 
that are irradiated [104]. In fact, pro-inflammatory and ROS-generating cytokines 
such as tumor necrosis factor alpha (TNF-α) may be released upon radiation expo-
sure, which may perpetuate the damage enacted by ROS [111]. Thus, key pathways 
such as DNA repair, proliferation, and cell death can be altered in cells beyond those 
that are irradiated [111].
4.3 Prominent cancer genes affected by radon
ROS-induced DNA damage is a large factor in radon-induced carcinogenesis, 
thus, many of the examinations into genes affected by radon are relevant to DNA-
repair and apoptotic pathways. Naturally, a heavy focus is placed on TP53. Many 
investigations into TP53 examine whether hotspot mutations in TP53 can act as a 
molecular signal for radon-induced genotoxicity in at-risk populations. Although 
TP53 is observed to be altered in high exposure populations, there are limited 
observations available to suggest a consistent mutational landscape [112]. However, 
the role of TP53 in the molecular response to radon exposure may be relevant to 
the bystander effect, wherein TP53 may mediate the inhibition of response signals 
coming from irradiated cells [103]. Additionally, other key lung cancer-related genes 
may also be mutated by radon exposure, including EGFR and phosphatase and ten-
sin homolog (PTEN), but the exact mechanisms remain to be characterized [113].
As previously discussed, radon may also exhibit its carcinogenic effects epige-
netically, as evidenced by the promoter hypermethylation of the tumor suppressor 
genes CDKN2A and MGMT. In normal human lung cell lines, miRNAs shown to 
be primarily involved in cell proliferation, differentiation, and adhesion displayed 
aberrant expression upon radon exposure [114]. Moreover, the miRNA let-7e—an 
epigenetic regulator of the RAS oncogene—was found to be upregulated upon low 
radon exposure [115]. In this study, the upregulation of miRNAs targeting tumor 
suppressor genes was also noted, including PTEN, which may present an alternative 
mechanism of radon-induced carcinogenesis.
Finally, a number of studies have examined the effect of genetic polymorphisms 
of DNA damage repair genes in the outcome of individuals exposed to radon. For 
instance, individuals with a polymorphism leading to the Asp1104His substitution of 
DNA repair gene ERCC5 (XpG) displayed a higher frequency of micronuclei in their 
lymphocytes, representative of elevated cytogenetic damage and decreased radio-
sensitivity [116]. Alternatively, the absence of GSTM1 and GSTT1, members of the 
glutathione-s-transferase enzyme family—critical to detoxification and excretion—
is associated with an increased risk of lung cancer development [117, 118]. When 
radon exposure is considered, individuals with null alleles show a doubly increased 
odds ratio of lung cancer development [118]. Notably, this enzyme is relevant in the 
biotransformation and excretion of arsenic, suggesting similar carcinogenic path-
ways between these two environmental agents.
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Taken together, the molecular landscape of radon-induced carcinogenesis is 
complex and diverse, with effects being observed at the genetic, epigenetic and 
extracellular level. Future studies may examine the underlying molecular events 
common to radon-induced lung cancer, to aid in diagnosis and perhaps novel  
treatment strategies.
5. Common oncogenic features exhibited by environmental carcinogens
The landscape of the genomic disruptions induced by environmental carcino-
gens is extensive. It has been demonstrated that these compounds can induce 
alterations such as chromosomal abnormalities, DNA double-strand breaks, gene 
expression dysregulation, and epigenetic aberrations. While each agent presents a 
unique mechanism and clinical challenge, a number of parallels can be seen. The 
molecular effects of exposure to arsenic, asbestos, and radon converge in that each 
compound can result in DNA damage induced by ROS and inflammation. As these 
events occur early during tumor development, the identification of the underlying 
genomic and epigenomic abnormalities caused by these compounds is extremely 
relevant in identifying early oncogenic events and individual susceptibility 
differences.
Although the intricacies of the molecular mechanisms of alteration may differ 
between the various toxic agents, ROS generation is a common outcome of exposure 
that can lead to extensive DNA damage and further perturbations in various cellular 
compartments and processes [119]. As mitochondria are one of the primary sources 
of ROS, they are also key targets of oxidative toxicity [120]. Arsenic exposure is 
associated with dysfunction of the mitochondria, through the ability of its metabo-
lites to disrupt the mitochondrial membrane potential and reduce mitochondrial 
ATP levels, as well as ROS-induced mitochondrial damage [121, 122]. Mitochondrial 
damage induced by arsenic can then lead to numerous alterations in key signaling 
pathways, such as the decreased expression of apoptotic regulator protein Bcl-2 
[122]. Regardless of the molecular mechanism, mitochondrial insult culminates in 
apoptosis and increased inflammation, in addition to the exacerbation of reactive 
species generation; events that commonly precede tumorigenesis [121, 123].
Another frequently observed early consequence of exposure to environmental 
carcinogens is an inflammatory response. Indeed, inflammation caused by infiltrat-
ing immune cells underlies numerous hallmarks of cancer biology by providing  
key molecules for tumor survival and growth, as well as the promotion of genomic 
aberrations, again through the generation of ROS [124]. Asbestos-induced car-
cinogenesis is thought to rely heavily on the inflammatory response, where the 
macrophages of the innate immune system attempt to clear the carcinogenic fibers 
through phagocytosis [125]. However, these fibers are inherently difficult to digest, 
leading to the eventual death of the macrophage and subsequent release of pro-
inflammatory cytokines, ROS, and other growth factors [126]. Interestingly, many 
malignancies have noticeable local immune responses prior to tumor development, 
highlighting the complex and dichotomous role of host immune cells in both pro- 
and anti-tumor functions [127]. Thus, exposure to environmental carcinogens 
threatens the genetic and epigenetic landscape of oncogene expression in the devel-
opment of malignancies, and subsequently changes cellular and systemic processes.
The intertwined role of genetic and epigenetic aberrations resulting from expo-
sure to these compounds highlights the complexity of environmentally-induced lung 
cancer. However, the carcinogenic mechanisms associated with exposure to these 
agents have been mainly identified using a “one-agent-at-a-time” approach. Further, 
we have yet to understand how these factors interplay with one another in cases of 
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combined exposure and how individual genomes modulate the molecular events 
that arise following exposure. For example, it is difficult to accurately assess the 
relative risk of lung cancer in an individual who is exposed to occupational asbestos, 
arsenic-contaminated water, and high levels of domestic indoor air radon. Whether 
these factors synergize in terms of their molecular effects is not clearly understood 
and has critical implications to patient monitoring and disease management.
Recently, the idea of the human exposome has sought to provide a method for 
analyzing individual risk factors by integrating the effects of factors ranging from 
DNA-level alterations to geographic location. The human exposome is defined as 
the sum of every exposure to which an individual is subjected to from conception to 
death [128]. The exposome is dynamic: the nature, amount, and conditions of expo-
sure change over time. It also includes exposure from internal (e.g., metabolism, 
endogenous hormones, gut microflora, inflammation, oxidative stress, etc.) and 
external (e.g., radiation, infectious agents, chemical contaminants and environ-
mental pollutants, among others) sources [129]. The lungs are one of the organs at 
the highest risk of disease development from environmental exposures as the lung 
exposome can be comprised of an array of molecules and environmental insults. 
Arsenic, asbestos, and radon, together with air pollution and tobacco smoke, 
constitute a fraction of the complex mix of environmental carcinogens posing 
risks for developing thoracic malignancies in humans. However, understanding the 
oncogenic events following exposure to these agents may allow for the identification 
of key intervention points to minimize environmentally-induced lung cancer in 
at-risk populations.
6. Translational outlook for environmentally-induced cancer
As the molecular mechanisms of environmentally-induced carcinogenesis con-
tinue to emerge, a need to characterize the clinical utility of these findings should 
be underscored. This need is further emphasized by the complex interplay between 
the numerous features of the lung exposome. Many of the single cancer-associated 
genes that are affected by exposure to these environmental agents are promising 
therapeutic intervention points. For instance, targeted inhibitors of EGFR (e.g., 
erlotinib, afatinib)—a protein transcribed from a gene commonly up-regulated 
upon exposure to arsenic—are used in lung cancer treatment to interfere with the 
aberrant growth pathways activated by the upregulation of this signaling receptor 
[130]. Additionally, the association between radon exposure and ALK gene rear-
rangements in lung cancer patients may be amenable to therapy with inhibitors of 
the ALK protein (e.g., crizotinib, ceritinib) [131]. However, patients that do not 
present with alterations in genes that are clinically actionable remain extremely 
difficult to treat beyond standard regimes. Thus, it is critical to analyze the onco-
genetic alterations induced by environmental carcinogens, to not only identify 
the contribution of each of these widely-distributed agents to tumorigenesis, but 
also to direct the development of novel treatment and risk-management strategies. 
Concurrent analysis of altered genes, transcripts, and proteins may help to parse out 
the risk associated with the varying molecular aberrations that have been observed 
to be induced by these compounds [132]. This approach, while difficult in terms of 
scale, necessitates the use of geographic, demographic, and exposome level data, 
which can be scarce in areas where environmental carcinogen levels are especially 
concerning. Table 1 summarizes the currently available sources of information for 
carcinogens found in the environment that are associated with lung cancer. Overall, 
future mitigation of the environmental risk factors that lead to lung cancer will rely 












The IARC Monographs, International Agency for Research on 
Cancer
http://monographs.iarc.fr/ Compilation of factors that increase the risk of human cancer: 
occupational exposures, physical agents, biological agents, and lifestyle
Carcinogens, American Cancer Society http://www.cancer.org/Cancer/CancerCauses/
OtherCarcinogens/index
Environmental carcinogens from different sources (e.g., indoor, 
pollution, medical tests)




Information of environmental carcinogens to affect human health.




Information on the 10 chemicals or groups of chemicals of major public 
health concern
Radon and Health, WHO http://www.who.int/mediacentre/factsheets/
fs291/en/
Health effects and guide line of Radon.
Arsenic Fact Sheet, WHO http://www.who.int/mediacentre/factsheets/
fs372/en/
Contents include health effects, prevention, and control on Arsenic.
Elimination of asbestos-related diseases, WHO http://www.who.int/mediacentre/factsheets/
fs343/en/
Information about asbestos related diseases.




Information on human health impacts associated with environmental 
exposures
Work-Related Lung Disease (WoRLD) Surveillance System, 
National Institute for Occupational Safety and Health (NIOSH)
http://www2.cdc.gov/drds/WorldReportData/ Contents on occupationally-related respiratory disease surveillance 
data.
U.S. Geological Survey (USGS) http://www.usgs.gov/ Organization that provides impartial information on the health of U.S. 
environment and the natural hazards
CARcinogen EXposure Canadian Surveillance Project (CAREX) http://www.carexcanada.ca/ Project that combines academic expertise and government resources to 
generate an evidence-based carcinogen surveillance program




Information about exposure to environmental carcinogen and the risk 
for lung cancer.
Table 1. 
Sources of information on environmental carcinogens associated with lung cancer.
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7. Conclusions and future directions
The geographical conditions facilitating human exposure to environmental 
lung carcinogens such as arsenic, asbestos and radon occur commonly across 
the globe. While millions of individuals are known to be exposed to potentially 
damaging doses of these carcinogens, another significant part of the population 
is unaware of its exposure. Despite the worldwide impact of the public health 
risk posed by these compounds, the genomic and epigenetic consequences of 
these exposures are drastically understudied. Barriers such as: (i) availability 
of individual-level exposure data; (ii) collection of genomic, epigenomic, and 
transcriptomic readouts following acute and chronic exposure to carcinogens; 
and (iii) obtaining enough samples to reach statistical power; impose even 
further challenges to determining the true extent of environmentally-induced 
health effects.
Understanding these mechanisms could have a significant impact on the estab-
lishment of safe exposure limits for each of these agents. For instance, most of the 
current frameworks used to regulate arsenic exposure in drinking water have been 
derived from studies performed in specific populations exposed to high levels of 
arsenic, such as Bangladesh, Chile, and China [9, 133, 134]. However, an increased 
risk of arsenic-related health effects (including cancer) has been documented at 
levels below current safety thresholds that are commonly found in water sources 
throughout North America and Europe [7]. Thus, characterizing the effects of 
these agents at the genomic/epigenomic level will not only aid in determining the 
oncogenes that are perturbed in environmentally-induced lung cancers, but may 
also uncover early molecular events that can be used as diagnostic and prognostic 
markers.
The fraction of lung cancer patients who have never smoked or have ceased 
smoking is likely to increase in the coming years. Exposure to environmental car-
cinogens, such as arsenic, asbestos, and radon will play a key role in their etiology. 
Further elucidation of the detailed mechanisms driving environmentally-induced 
lung tumors will provide the much-needed insight to define specific detection meth-
ods and intervention strategies. Collectively, uncovering these carcinogen-specific 
mechanisms, as well as the affected genes driving malignant transformation, will 
greatly contribute to the development of personalized approaches to provide better 
support to lung cancer patients.
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